Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 612

    1.

    Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group.

    Chemello L, Cavalletto L, Casarin C, Bonetti P, Bernardinello E, Pontisso P, Donada C, Belussi F, Martinelli S, Alberti A.

    Ann Intern Med. 1996 Jun 15;124(12):1058-60.PMID: 8633819 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy.

    Marcellin P, Boyer N, Gervais A, Martinot M, Pouteau M, Castelnau C, Kilani A, Areias J, Auperin A, Benhamou JP, Degott C, Erlinger S.

    Ann Intern Med. 1997 Nov 15;127(10):875-81.PMID: 9382365 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy.

    Shindo M, Arai K, Sokawa Y, Okuno T.

    Ann Intern Med. 1995 Apr 15;122(8):586-91.PMID: 7887552 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.

    Bizollon T, Ahmed SN, Radenne S, Chevallier M, Chevallier P, Parvaz P, Guichard S, Ducerf C, Baulieux J, Zoulim F, Trepo C.

    Gut. 2003 Feb;52(2):283-7.PMID: 12524414 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Permanent response to alpha-interferon therapy in chronic hepatitis C is preceded by rapid clearance of HCV-RNA from serum.

    Ampurdanés S, Olmedo E, Maluenda MD, Forns X, López-Labrador FX, Costa J, Sánchez-Tapias JM, de Anta MT, Rodés J.

    J Hepatol. 1996 Dec;25(6):827-32.PMID: 9007709 [PubMed - indexed for MEDLINE]Related articles

    6.

    Patterns of hepatitis C viremia in patients receiving hemodialysis.

    Umlauft F, Gruenewald K, Weiss G, Kessler H, Urbanek M, Haun M, Santner B, Koenig P, Keeffe EB.

    Am J Gastroenterol. 1997 Jan;92(1):73-8.PMID: 8995941 [PubMed - indexed for MEDLINE]Related articles

    7.

    Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C.

    Martinot M, Marcellin P, Boyer N, Detmer J, Pouteau M, Castelnau C, Degott C, Aupérin A, Collins M, Kolberg J, Wilber J, Benhamou JP, Erlinger S.

    Ann Intern Med. 1997 Jun 1;126(11):874-81.PMID: 9163288 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.

    Mizokami M, Orito E, Gibo Y, Suzuki K, Ohba K, Ohno T, Lau JY.

    Liver. 1996 Feb;16(1):23-7.PMID: 8868074 [PubMed - indexed for MEDLINE]Related articles

    9.

    Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot study.

    Flichman D, Colombatto P, Randone A, Baldi M, Bellati G, Negro F, Oliveri F, Colucci G, Verme G, Bonino F, Brunetto MR.

    Clin Diagn Virol. 1997 May;8(1):63-70.PMID: 9248659 [PubMed - indexed for MEDLINE]Related articles

    10.

    Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.

    Piccinino F, Felaco FM, Sagnelli E, Aprea L, Messina V, Pasquale G, Filippini P, Scolastico C.

    Res Virol. 1998 Sep-Oct;149(5):283-91.PMID: 9879606 [PubMed - indexed for MEDLINE]Related articles

    11.

    Long-term carriage of hepatitis C virus with normal aminotransferase after interferon treatment in patients with chronic hepatitis C.

    Kakumu S, Yoshika K, Tanaka K, Higashi Y, Kurokawa S, Hirofuji H, Kusakabe A.

    J Med Virol. 1993 Sep;41(1):65-70.PMID: 8228941 [PubMed - indexed for MEDLINE]Related articles

    12.

    Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon alpha-2b for chronic hepatitis type C. Results of a multicenter randomized trial.

    Saracco G, Borghesio E, Mesina P, Solinas A, Spezia C, Macor F, Gallo V, Chiandussi L, Donada C, Donadon V, Spirito F, Mangia A, Andriulli A, Verme G, Rizzetto M.

    J Hepatol. 1997 Jul;27(1):56-62.PMID: 9252074 [PubMed - indexed for MEDLINE]Related articles

    13.

    Viremia after one month of interferon therapy predicts treatment outcome in patients with chronic hepatitis C.

    Gavier B, Martínez-González MA, Riezu-Boj JI, Lasarte JJ, Garcia N, Civeira MP, Prieto J.

    Gastroenterology. 1997 Nov;113(5):1647-53.PMID: 9352868 [PubMed - indexed for MEDLINE]Related articles

    14.

    Loss of serum HCV RNA at week 4 of interferon-alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C.

    Orito E, Mizokami M, Suzuki K, Ohba K, Ohno T, Mori M, Hayashi K, Kato K, Iino S, Lau JY.

    J Med Virol. 1995 Jun;46(2):109-15.PMID: 7636496 [PubMed - indexed for MEDLINE]Related articles

    15.

    Baseline level and early suppression of serum HCV RNA for predicting sustained complete response to alpha-interferon therapy.

    Izopet J, Payen JL, Alric L, Sandres K, Charlet JP, Vinel JP, Duffaut M, Pascal JP, Puel J.

    J Med Virol. 1998 Feb;54(2):86-91.PMID: 9496364 [PubMed - indexed for MEDLINE]Related articles

    16.

    A long-term follow-up study of interferon treatment for chronic hepatitis C in Japanese patients with congenital bleeding disorders.

    Yamada M, Fukuda Y, Koyama Y, Nakano I, Urano F, Isobe K, Takamatsu J, Imoto M, Hayakawa T.

    Eur J Haematol. 1996 Aug;57(2):165-70.PMID: 8856094 [PubMed - indexed for MEDLINE]Related articles

    17.

    A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.

    Fong TL, Han SH, Tsai NC, Morgan TR, Mizokami M, Qian D, Phan C, Goad K, Redeker AG.

    J Hepatol. 1998 Mar;28(3):369-74.PMID: 9551672 [PubMed - indexed for MEDLINE]Related articles

    18.

    Long-term biochemical and virological response to natural interferon-alpha in patients with chronic hepatitis C.

    Hagiwara H, Hayashi N, Kasahara A, Oshita M, Katayama K, Naito M, Masuzawa M, Yoshihara H, Shimizu Y, Fusamoto H, Kamada T.

    Dig Dis Sci. 1996 May;41(5):1001-7.PMID: 8625742 [PubMed - indexed for MEDLINE]Related articles

    19.

    Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up.

    Knolle PA, Kremp S, Höhler T, Krummenauer F, Schirmacher P, Gerken G.

    J Viral Hepat. 1998 Nov;5(6):399-406.PMID: 9857349 [PubMed - indexed for MEDLINE]Related articles

    20.

    Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group.

    Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Gutigard BG, Skjaerven R, Prescott LE, Simmonds P.

    Scand J Infect Dis. 1997;29(1):17-22.PMID: 9112292 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data